(Q57010004)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10914557%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

title

Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10914557%20AND%20SRC:MED&resulttype=core&format=json

stem cell transplantation

8 November 2019

main subject

1 reference

1 reference

P Tosi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10914557%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

E Zamagni

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10914557%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

S Ronconi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10914557%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

M Benni

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10914557%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

M R Motta

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10914557%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

S Rizzi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10914557%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

S Tura

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10914557%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

M Cavo

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10914557%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

language of work or name

English

0 references

publication date

1 July 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10914557%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10914557%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10914557%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10914557%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

1310-1313

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10914557%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2401819

8 November 2019

exact match

0 references

cites work

Renal failure in multiple myeloma. Pathogenesis and prognostic implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401819

7 January 2021

Renal function in newly diagnosed multiple myeloma--a demographic study of 1353 patients. The Nordic Myeloma Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401819

7 January 2021

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401819

7 January 2021

Effect of renal dysfunction in dogs on the disposition and marrow toxicity of melphalan

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401819

7 January 2021

Pharmacokinetics of oral melphalan in relation to renal function in multiple myeloma patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401819

7 January 2021

Peripheral blood stem cell transplantation in a multiple myeloma patient with end-stage renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401819

7 January 2021

High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401819

7 January 2021

Effect of high-dose melphalan and peripheral blood stem cell transplantation on renal function in patients with multiple myeloma and renal insufficiency: a case report and review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401819

7 January 2021

VAD-based regimens as primary treatment for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401819

7 January 2021

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401819

7 January 2021

Recombinant tissue plasminogen activator (rtPA) for the treatment of hepatic veno-occlusive disease (VOD)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401819

7 January 2021

Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish Registry. Spanish Registry for Transplant in MM (Grupo Español de Trasplante Hematopoyético-GETH) and PETHEMA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401819

7 January 2021

High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401819

7 January 2021

Pharmacokinetic and metabolic studies of high-dose busulphan in adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401819

7 January 2021

The systemic administration of intravenous melphalan

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401819

7 January 2021

High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401819

7 January 2021

Melphalan 220 mg/m2 followed by peripheral blood stem cell transplantation in 27 patients with advanced multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401819

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2401819

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10914557%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference